Test Bank Advanced Pharmacology For Prescribers 1St Edition By Luo Kayingo | 2025 Update

TEST BANK ADVANCED
PHARMACOLOGY FOR PRESCRIBERS
1ST EDITION BY LUO KAYINGO | 2024
UPDATE

, Table of Contents
’ ’

Chapter’ 1:’An’Introduction’to’Evidence-Based’Clinical’ Practice’Guidelines.................................................. 3
Chapter’ 2:’Pharmacokinetics’ /Chapter3:’ Pharmacodynamics ...................................................................... 13
Chapter4:’Pharmacogenetics’ and’Pharmacogenomics.................................................................................. 25
Chapter’ 5:’Pharmacology’ Across’ the’Life’Span............................................................................................ 30
Chapter’ 6:’Drug-Therapy’Prescribing’in’Special’Populations ....................................................................... 36
Chapter’ 7:’Drug’Development’ and’Approval ............................................................................................... 45
Chapter’8-Chapter’10:’Foundations’of’Prescription’Writing’Chapter’9:’ResponsibleControlled-
Substance‘Prescribing’Chapter’10:’Antibiotic’Stewardship........................................................................... 51
Chapter’ 11:’ Applied’Calculations’ for’ Prescribing ........................................................................................ 58
Chapter’12-:’Promoting’Adherence’With’Pharmacotherapy’II:’System-Specific’and’Patient-
Focused‘Prescribing’Chapter’13:’Pharmacotherapy’for’Ear,’Nose,’Mouth,’andThroat’Conditions’/Chapter’14:‘
Pharmacotherapy’for’Eye’Conditions ........................................................................................................... 67
Chapter’ 15:’Pharmacotherapy’for’ Skin’ Conditions ...................................................................................... 74
Chapter’ 16:’Pharmacotherapy’ for’ Neurologic’ Conditions ............................................................................ 81
Chapter’ 17:’Pharmacotherapy’for’ Cardiovascular’ Conditions ..................................................................... 94
Chapter’ 18:’Pharmacotherapy’for’ Respiratory’Conditions ......................................................................... 106
Chapter’19:’Pharmacotherapy’for’Gastrointestinal’Conditions’and’Conditions’RequiringNutritional‘Support
................................................................................................................................................................... 117
Chapter’ 20:’Pharmacotherapy’for’ Genitourinary’Conditions...................................................................... 128
Chapter’21:’Pharmacotherapy’for’ Renal,’Acid–Base,’ Fluid,’and’Electrolyte’Disorders .............................. 133
Chapter’ 22:’Pharmacotherapy’ for’ Musculoskeletal’and’Rheumatologic’ Conditions .................................. 146
Chapter’ 23:’Therapeutic’ Applications’ of’ Immunology’ and’ Vaccines ........................................................ 158
Chapter’ 24:’Pharmacotherapy’ for’ Endocrine’Disorders ............................................................................. 163
Chapter’ 25:’Pharmacotherapy’for’Hematologic’ Disorders ......................................................................... 174
Chapter’ 26:’Hematology/Oncology’and’Supportive’ Care’for’ the’Nononcologist ........................................ 190
Chapter’ 27:’Pharmacotherapy’ Related’to’Women’s’ Health’ Conditions...................................................... 196
Chapter’ 28:’Pharmacotherapy’Related’to’Men’s’ Health’Conditions ........................................................... 211
Chapter’ 29:’Pharmacotherapy’ Related’ to’Transgender’ Care ...................................................................... 217
Chapter’ 30:’Antimicrobial’Pharmacotherapy ............................................................................................. 224
Chapter’ 31:’Antiretroviral’Pharmacotherapy.............................................................................................. 235
Chapter’32:’Psychopharmacology’and’Integrative’Health:’Combined’Treatment’ofPsychiatric’and‘Neurocog
nitive’ Conditions ........................................................................................................................................ 247
Chapter’ 33:’Pharmacotherapy’for’ Pain’Management ................................................................................. 257
Chapter’ 34:’Substance’Use’Disorder’ III:’Health’Promotion’and’Maintenance ............................................ 267
Chapter’ 35:’Over-the-Counter’ Medications ............................................................................................... 283
Chapter’ 36:’Pharmacotherapy’for’ Obesity.................................................................................................. 291

,Chapter’1:’An’Introduction’to’Evidence-Based’Clinical’Practice’Guidelines
MULTIPLE’CHOICE

• What’is’the’primary’ purpose’ of’the’ nursing’ assessment?

A. Identifying’ underlying’ pathologic’ conditions
B. Assisting’ the’ physician’ in’identifying’ medical’ conditions
C. Determining’ the’ patients’mental’status
D. Exploring’ patient’ responses’ to’ health’ problems


ANS:’D

A’nursing’assessment’is’done’to’identify’the’patients’response’to’health’proble
ms.’During’the’nursing’assessment’phase,’a’comprehensive’information’base’
is’developed’through’a’physical’examination,’nursing’history,’medication’hist
ory,’and’professional’observation.’Identifying’underlying’pathologic’conditi
ons’and’assisting’the’physician’in’identifying’medical’conditions’is’not’part’of’
the’nursing’process.’Determining’the’patients’ mental’status’ is’one’part’ of’the’
nursing’ assessment,’ but’ it’ is’ not’the’primary’purpose.

DIF:’Cognitive’Level:’Comprehension’
REF:’dm’36’OBJ:’1’|’3’TOP:’Nursing’Pro
cess’Step:’Assessment
MSC:’NCLEX’ Client’ Needs’ Category:’ Health’Promotion’ and’ Maintenance

• What’is’the’basis’ of’the’NANDA’I’ taxonomy?

A. Functional’ health’patterns
B. Human’response’ patterns
C. Basic’ human’ needs
D. Pathophysiologic’ needs

ANS:’B

The’ NANDA’ I’ taxonomy’ identifies’ human’ response’ patterns.’Functional
’components’of’health’patterns’are’limited’to’activity,’fluid’volume,’nutrition

,’self’care,’and’sensory’perception.’Basic’human’needs’comprise’less’than’me
rely’health’patterns.’ Pathophysiologic’needs’ are’not’part’of’the’scope’of’NA
NDA’I.

, DIF:’Cognitive’Level:’Knowledge’REF:
’pp.’37-38’OBJ:’5’TOP:

Nursing’Process’Step:’Diagnosis
MSC:’NCLEX’ Client’ Needs’ Category:’ Physiological’ Integrity

• Which’task’is’included’ in’the’assessment’ step’ of’the’ nursing’ process?

A. Establishing’ patient’ goals/outcomes
B. Implementing’ the’ nursing’ care’ plan’ (NCP)
C. Measuring’ goal/outcome’ achievement
D. Collecting’ and’ communicating’ data


ANS:’D

Data’are’collected’and’communicated’in’the’assessment’phase’of’the’nursing’p
rocess.’Establishing’goals’is’the’function’of’planning.
Implementing’the’NCP’is’the’function’of’implementation.’Measuring’outcom
e’achievement’is’the’function’of’evaluation.

DIF:’Cognitive’Level:’Comprehension’
REF:’dm’36’OBJ:’2’|’3’TOP:’Nursing’Pr
ocess’Step:’Assessment
MSC:’NCLEX’ Client’ Needs’ Category:’ Health’Promotion’ and’ Maintenance

• Which’statement’ regarding’ nursing’ diagnoses’ is’ accurate?

a. Nursing’ diagnoses’remain’the’same’ for’as’ long’as’the’disease’ is’ present.
b. Nursing’ diagnoses’ are’ written’ to’ identify’disease’states.

c. Nursing’ diagnoses’ describe’ patient’ problems’ that’ nurses’ treat.
d. Nursing’ diagnoses’ identify’causes’ related’to’illness.


ANS:’C

Diagnostic’statements’identify’problems’a’nurse’is’independently’able’to’trea
t’within’the’scope’of’professional’practice.’Nursing’diagnoses’vary’with’the’c
hanging’condition’of’the’patient.’The’response’patterns’are’unique’to’the’pati
ent’and’are’not’disease’specific.’Nursing’diagnoses’describe’the’patients’hum
an’response’pattern.

DIF:’ Cognitive’ Level:’ Comprehension